Search research articles
Contact Us
Filters
Showing results (81-90 of 275) with videos related to
Page
of 28
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 30, 2022
KEAP1-Mutant NSCLC: The Catastrophic Failure of a Cell-Protecting Hub
Stefano Scalera, Marco Mazzotta, Clelia Cortile, et al.
Anticancer Research
|
February 5, 2020
Prognostic Value of p16 Protein in Patients With Surgically Treated Non-small Cell Lung Cancer; Relationship With Ki-67 and PD-L1
Aldo Pezzuto, Federico Cappuzzo, Manolo D'Arcangelo, et al.
Cancer Treatment Reviews
|
October 23, 2024
Neoadjuvant immunotherapy strategies for resectable non-small cell lung cancer (NSCLC): Current evidence among special populations and future perspectives
Claudia Parisi, Pamela Abdayem, Marco Tagliamento, et al.
Molecular Diagnosis & Therapy
|
November 23, 2021
Worldwide Prevalence of Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer: A Meta-Analysis
Barbara Melosky, Kato Kambartel, Maik Häntschel, et al.
Frontiers in Oncology
|
August 22, 2025
Short term outcomes of robotic surgery after neoadjuvant treatment for locally advanced NSCLC: a comparison with the open approach
Filippo Tommaso Gallina, Riccardo Tajè, Daniele Forcella, et al.
Lancet (London, England)
|
August 9, 2024
New promises and challenges in the treatment of advanced non-small-cell lung cancer
May-Lucie Meyer, Bailey G Fitzgerald, Luis Paz-Ares, et al.
Critical Reviews in Oncology/Hematology
|
May 30, 2024
Rediscovering immunohistochemistry in lung cancer
Anna La Salvia, May-Lucie Meyer, Fred R Hirsch, et al.
Nature Reviews. Clinical Oncology
|
January 20, 2025
Circulating tumour DNA in early stage and locally advanced NSCLC: ready for clinical implementation?
Nicola Normanno, Alessandro Morabito, Anna Maria Rachiglio, et al.
Critical Reviews in Oncology/Hematology
|
March 15, 2006
Clinical experience with gefitinib: an update
Federico Cappuzzo, Giovanna Finocchiaro, Giulio Metro, et al.
JTO Clinical and Research Reports
|
August 3, 2023
Pretreated <i>EGFR</i><sup></sup>/<i>BRAF</i><sup></sup> Lung Adenocarcinoma With Leptomeningeal Disease Achieving Long-Lasting Disease Control on Osimertinib, Dabrafenib, and Trametinib: A Case Report
Corrado Orciuolo, Federico Cappuzzo, Lorenza Landi, et al.
Page
of 28
Search research articles
Search
Showing results (81-90 of 275) with videos related to
Sort By:
Page
of 28
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 30, 2022
KEAP1-Mutant NSCLC: The Catastrophic Failure of a Cell-Protecting Hub
Stefano Scalera, Marco Mazzotta, Clelia Cortile, et al.
Anticancer Research
|
February 5, 2020
Prognostic Value of p16 Protein in Patients With Surgically Treated Non-small Cell Lung Cancer; Relationship With Ki-67 and PD-L1
Aldo Pezzuto, Federico Cappuzzo, Manolo D'Arcangelo, et al.
Cancer Treatment Reviews
|
October 23, 2024
Neoadjuvant immunotherapy strategies for resectable non-small cell lung cancer (NSCLC): Current evidence among special populations and future perspectives
Claudia Parisi, Pamela Abdayem, Marco Tagliamento, et al.
Molecular Diagnosis & Therapy
|
November 23, 2021
Worldwide Prevalence of Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer: A Meta-Analysis
Barbara Melosky, Kato Kambartel, Maik Häntschel, et al.
Frontiers in Oncology
|
August 22, 2025
Short term outcomes of robotic surgery after neoadjuvant treatment for locally advanced NSCLC: a comparison with the open approach
Filippo Tommaso Gallina, Riccardo Tajè, Daniele Forcella, et al.
Lancet (London, England)
|
August 9, 2024
New promises and challenges in the treatment of advanced non-small-cell lung cancer
May-Lucie Meyer, Bailey G Fitzgerald, Luis Paz-Ares, et al.
Critical Reviews in Oncology/Hematology
|
May 30, 2024
Rediscovering immunohistochemistry in lung cancer
Anna La Salvia, May-Lucie Meyer, Fred R Hirsch, et al.
Nature Reviews. Clinical Oncology
|
January 20, 2025
Circulating tumour DNA in early stage and locally advanced NSCLC: ready for clinical implementation?
Nicola Normanno, Alessandro Morabito, Anna Maria Rachiglio, et al.
Critical Reviews in Oncology/Hematology
|
March 15, 2006
Clinical experience with gefitinib: an update
Federico Cappuzzo, Giovanna Finocchiaro, Giulio Metro, et al.
JTO Clinical and Research Reports
|
August 3, 2023
Pretreated <i>EGFR</i><sup></sup>/<i>BRAF</i><sup></sup> Lung Adenocarcinoma With Leptomeningeal Disease Achieving Long-Lasting Disease Control on Osimertinib, Dabrafenib, and Trametinib: A Case Report
Corrado Orciuolo, Federico Cappuzzo, Lorenza Landi, et al.
Page
of 28